MedTrace Logo

Optimization of Selenoprotein P in Chinese Subjects

NCT00428649 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2012-03-07

No results posted yet for this study

Summary

The purpose of this study is to determine the amount of selenium as selenomethionine that is required to optimize selenoprotein P in selenium-deficient Chinese subjects

Conditions

  • Selenium Deficiency

Interventions

DIETARY_SUPPLEMENT

20 µg selenium

20 µg selenium as selenomethionine

DIETARY_SUPPLEMENT

40 µg selenium

40 µg selenium as selenomethionine

DIETARY_SUPPLEMENT

60 µg selenium

60 µg selenium as selenomethionine

DIETARY_SUPPLEMENT

80 µg selenium

80 µg selenium as selenomethionine

DIETARY_SUPPLEMENT

100 µg selenium

100 µg selenium as selenomethionine

DIETARY_SUPPLEMENT

120 µg selenium

120 µg selenium as selenomethionine

DIETARY_SUPPLEMENT

placebo

placebo

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Raymond F Burk, M.D. · Vanderbilt University

  • Yiming Xia, Ph.D. · Sichuan CDC, Chengdu

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2007-12-31
Completion
2008-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00428649 on ClinicalTrials.gov